Biotechnology

FTC Moves to Block Illumina Acquisition of PacBio, Citing Monopoly

by Kyle Murphy, PhD

On Tuesday, the Federal Trade Commission (FTC) took legal action to block Illumina Inc.’s acquisition of Pacific Biosciences of California (PacBio) as part of an administrative complaint alleging...

Pharmaceutical Companies Made Acquisitions a Top Priority in 2019

by Kyle Murphy, PhD

By the midway point of 2019, more than $200 billion had exchanged hands, exceeding previous years of $198 billion and $178 in 2018 and 2017, respectively. And the recent closing of Bristol-Myers Squibb...